Perreault, S., Larouche, V., Tabori, U., Hawkins, C., Lippé, S., Ellezam, B., . . . Jabado, N. (2020). LGG-25. A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY. TRAM-01. Neuro Oncol.
Chicago ZitierstilPerreault, Sébastien, et al. "LGG-25. A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY. TRAM-01." Neuro Oncol 2020.
MLA ZitierstilPerreault, Sébastien, et al. "LGG-25. A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY. TRAM-01." Neuro Oncol 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.